Access Bio Inc - Asset Resilience Ratio

Latest as of June 2025: 12.52%

Access Bio Inc (950130) has an Asset Resilience Ratio of 12.52% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Access Bio Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩83.51 Billion

≈ $56.60 Million USD Cash + Short-term Investments

Total Assets

₩667.01 Billion

≈ $452.02 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Access Bio Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Access Bio Inc.

Liquid Assets Composition Over Time

This chart breaks down Access Bio Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 950130 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩83.51 Billion	12.52%
Total Liquid Assets	₩83.51 Billion	12.52%

Asset Resilience Insights

Moderate Liquidity: Access Bio Inc has 12.52% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Access Bio Inc Industry Peers by Asset Resilience Ratio

Compare Access Bio Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Green Cross Lab Cell Corporation KQ:144510	Diagnostics & Research	0.18%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Scope Fluidics SA WAR:SCP	Diagnostics & Research	16.51%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Check-Cap Ltd F:7CC	Diagnostics & Research	2.90%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%

Annual Asset Resilience Ratio for Access Bio Inc (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Access Bio Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.20%	₩76.60 Million ≈ $51.91K	₩503.98 Million ≈ $341.54K	+5.16pp
2023-12-31	10.04%	₩69.37 Billion ≈ $47.01 Million	₩691.14 Billion ≈ $468.37 Million	-46.28pp
2022-12-31	56.32%	₩393.51 Million ≈ $266.68K	₩698.71 Million ≈ $473.51K	+11.00pp
2021-12-31	45.32%	₩168.98 Million ≈ $114.52K	₩372.85 Million ≈ $252.67K	+15.74pp
2020-12-31	29.58%	₩46.27 Million ≈ $31.36K	₩156.42 Million ≈ $106.00K	+18.09pp
2019-12-31	11.49%	₩6.92 Million ≈ $4.69K	₩60.23 Million ≈ $40.81K	+0.77pp
2018-12-31	10.72%	₩9.09 Million ≈ $6.16K	₩84.82 Million ≈ $57.48K	+3.38pp
2017-12-31	7.34%	₩6.39 Million ≈ $4.33K	₩87.15 Million ≈ $59.06K	-20.09pp
2016-12-31	27.43%	₩25.02 Million ≈ $16.95K	₩91.22 Million ≈ $61.82K	+25.47pp
2015-12-31	1.96%	₩1.59 Billion ≈ $1.08 Million	₩81.12 Billion ≈ $54.97 Million	-21.63pp
2014-12-31	23.59%	₩18.62 Billion ≈ $12.62 Million	₩78.93 Billion ≈ $53.49 Million	+21.62pp
2013-12-31	1.97%	₩1.17 Billion ≈ $791.54K	₩59.19 Billion ≈ $40.11 Million	+1.22pp
2012-12-31	0.75%	₩219.00 Million ≈ $148.41K	₩29.09 Billion ≈ $19.71 Million	--

pp = percentage points

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$58.40 Million

₩86.18 Billion KRW

Market Cap Rank

#21417 Global

#1243 in Korea

Share Price

₩2450.00

Change (1 day)

-0.81%

52-Week Range

₩2020.00 - ₩2570.00

All Time High

₩29950.00